Literature DB >> 24518272

Acamprosate: an alcoholism treatment that may not be what we thought.

Markus Heilig1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24518272      PMCID： PMC3924516          DOI： 10.1038/npp.2013.272

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

1.  Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Authors:  John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel Hommer; Markus Heilig
Journal:  Arch Gen Psychiatry       Date:  2010-10

Review 2.  Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.

Authors:  Falk Kiefer; Karl Mann
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

3.  The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.

Authors:  Rainer Spanagel; Gurudutt Pendyala; Carolina Abarca; Tarek Zghoul; Carles Sanchis-Segura; Maria Chiara Magnone; Jesús Lascorz; Martin Depner; David Holzberg; Michael Soyka; Stefan Schreiber; Fumihiko Matsuda; Mark Lathrop; Gunter Schumann; Urs Albrecht
Journal:  Nat Med       Date:  2004-12-19       Impact factor: 53.440

4.  Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol.

Authors:  Roberto Rimondini; Christina Arlinde; Wolfgang Sommer; Markus Heilig
Journal:  FASEB J       Date:  2002-01       Impact factor: 5.191

5.  Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

Authors:  Barbara J Mason; Philippe Lehert
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

6.  Acamprosate produces its anti-relapse effects via calcium.

Authors:  Rainer Spanagel; Valentina Vengeliene; Bernd Jandeleit; Wolf-Nicolas Fischer; Kent Grindstaff; Xuexiang Zhang; Mark A Gallop; Elena V Krstew; Andrew J Lawrence; Falk Kiefer
Journal:  Neuropsychopharmacology       Date:  2013-09-30       Impact factor: 7.853
  6 in total
  5 in total

Review 1.  The development of acamprosate as a treatment against alcohol relapse.

Authors:  Peter R Kufahl; Lucas R Watterson; M Foster Olive
Journal:  Expert Opin Drug Discov       Date:  2014-09-26       Impact factor: 6.098

Review 2.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

3.  Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?

Authors:  Erin Kelty; Mishka Terplan; Melanie Greenland; David Preen
Journal:  Drugs       Date:  2021-04-08       Impact factor: 9.546

Review 4.  Acamprosate: A Review of Its Use in Alcohol Dependence.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

5.  Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.

Authors:  Tori L Schaefer; Matthew H Davenport; Lindsay M Grainger; Chandler K Robinson; Anthony T Earnheart; Melinda S Stegman; Anna L Lang; Amy A Ashworth; Gemma Molinaro; Kimberly M Huber; Craig A Erickson
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.